1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Viral Conjunctivitis Drugs Market 2016-2020

Global Viral Conjunctivitis Drugs Market 2016-2020

  • March 2016
  • -
  • Infiniti Research Limited
  • -
  • 53 pages

About Viral Conjunctivitis Drugs

Viral conjunctivitis, or pink eye, is a type of infectious conjunctivitis that is commonly caused by an adenovirus. Herpes simplex virus (HSV), picornavirus (enterovirus 70, Coxsackie A24), varicella-zoster virus, poxvirus (molluscum contagiosum and vaccinia), and human immunodeficiency virus (HIV) are some of the other viruses that are responsible for the infection. Discomfort through watery discharge is the main symptom of this highly contagious condition. It is often associated with keratoconjunctivitis, which results in slightly blurred vision. No specific treatment option is available for the infection, which heals by itself in 2-3 weeks. Antibiotics and anti-inflammatory drugs are used only if the condition persists. In certain instances, when the infection is serious or persists for weeks, topical antiviral drugs are used. Corneal lesions persist for months even after the condition heals.

Technavio’s analysts forecast the global viral conjunctivitis drugs market to grow at a CAGR of 2.41% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global viral conjunctivitis drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of viral conjunctivitis.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Viral Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Akorn
- Alcon
- Allergan
- Bausch & Lomb


Other prominent vendors
- Adenovir Pharma
- Marinomed Biotechnologie
- Mediolanum Laboratoires
- NanoViricides
- Nicox
- Novartis
- Panoptes Pharma
- Rapid Pathogen Screening
- Shire
- Starpharma
- Valeant Pharmaceuticals

Market driver
- Rising awareness
- For a full, detailed list, view our report

Market challenge
- Low diagnosis rate
- For a full, detailed list, view our report

Market trend
- Use of off-label drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents

Global Viral Conjunctivitis Drugs Market 2016-2020
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Disease overview
- Conjunctivitis
- Viral conjunctivitis
- Signs and symptoms
- Diagnosis
- Management
- Epidemiology
- Economic burden
PART 06: Pipeline analysis
- FST-100
- APD-209 eye drops
- SPL7013
- EKC-Cide
- PP-001
PART 07: Market landscape
- Market overview
- Market size and forecast
- Viral conjunctivitis drugs market in US
- Five forces analysis
PART 08: Market segmentation by route of administration
- Topical
- Oral
- Intravitreal
PART 09: Geographical segmentation
- Global viral conjunctivitis drugs market by geography 2015-2020
- Viral conjunctivitis drugs market in Americas
- Viral conjunctivitis drugs market in EMEA
- Viral conjunctivitis drugs market in APAC
PART 10: Market drivers
- Rising awareness
- Unmet needs for viral conjunctivitis
- High prevalence
PART 11: Impact of drivers
PART 12: Market challenges
- Low diagnosis rate
- Adverse effects and limited efficacy of drugs
- Satisfaction with existing therapies
- Availability of alternative therapies
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Strategic alliances and MandA
- Use of off-label drugs
- Rise in RandD
PART 15: Vendor landscape
- Akorn
- Alcon
- Allergan
- Bausch and Lomb
- Other prominent vendors
PART 16: Appendix
- List of abbreviations
PART 17: Explore Technavio





Exhibit 01: Product offerings
Exhibit 02: Types of conjunctivitis
Exhibit 03: Major types of viral conjunctivitis
Exhibit 04: Signs and symptoms of types of viral conjunctivitis
Exhibit 05: Diagnostic algorithm for viral conjunctivitis
Exhibit 06: Drugs used to treat conjunctivitis
Exhibit 07: Comparison of prevalent rates in different types of conjunctivitis among adults and pediatric population (%)
Exhibit 08: Global viral conjunctivitis drugs market: Pipeline portfolio
Exhibit 09: Global viral conjunctivitis drugs market 2015-2020 ($ millions)
Exhibit 10: Snapshot of global viral conjunctivitis drugs market
Exhibit 11: Percentage share of US in the global viral conjunctivitis drugs market 2015
Exhibit 12: Viral conjunctivitis drugs market in US 2015-2020 ($ millions)
Exhibit 13: Five forces analysis
Exhibit 14: Global viral conjunctivitis drugs market segment by route of administration
Exhibit 15: Global viral conjunctivitis drugs market by geography 2015
Exhibit 16: Viral conjunctivitis drugs market by geography 2015-2020 ($ millions)
Exhibit 17: Viral conjunctivitis drugs market in Americas 2015-2020 ($ millions)
Exhibit 18: Viral conjunctivitis drugs market in EMEA 2015-2020 ($ millions)
Exhibit 19: Viral conjunctivitis drugs market in APAC 2015-2020 ($ millions)
Exhibit 20: Global viral conjunctivitis drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 21: Impact of drivers
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Akorn: YOY growth and revenue generated from ophthalmic segment 2011-2013 ($ millions)
Exhibit 24: Akorn: Key takeaways
Exhibit 25: Alcon: Business segmentation by revenue 2014
Exhibit 26: Alcon: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 27: Alcon: Key takeaways
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Bausch and Lomb: Key takeaways

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Europe Market Report for Fundus Cameras 2017 - MedCore

Europe Market Report for Fundus Cameras 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

Europe Market Report for Slit Lamps 2017 - MedCore

Europe Market Report for Slit Lamps 2017 - MedCore

  • $ 5995
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Glaucoma Therapeutics Market: Overview Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.